Vericel (VCEL) Non-Current Debt (2010 - 2018)
Vericel's (VCEL) quarterly Non-Current Debt came in at $13.2 million in Q3 2018, up 78.15% year-on-year from $7.4 million in Q3 2017, and down 8.55% quarter-over-quarter from $14.4 million in Q2 2018.
Vericel (VCEL) Non-Current Debt (2010 - 2018) Analysis & Trends
Vericel has disclosed Non-Current Debt across 9 years of filings, most recently posting $13.2 million for Q3 2018.
- Non-Current Debt for Q3 2018 came in at $13.2 million, up 78.15% year-over-year; the trailing twelve-month figure through Sep 2018 was $13.2 million (up 78.15% YoY), and the FY2017 annual result was $16.9 million, up 52675.0% from the prior year.
- Non-Current Debt came in at $13.2 million for Q3 2018 at Vericel, down from $14.4 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $16.9 million in Q4 2017 to a low of $32000.0 in Q4 2016.
- The 5-year median for Non-Current Debt is $109000.0 (2014), against an average of $5.0 million.
- Across the five-year window, Non-Current Debt slumped 54.93% in 2016 and jumped 52675.0% in 2017, its largest moves.
- Vericel's Non-Current Debt stood at $109000.0 in 2014, then tumbled by 34.86% to $71000.0 in 2015, then slumped by 54.93% to $32000.0 in 2016, then surged by 52675.0% to $16.9 million in 2017, then decreased by 21.94% to $13.2 million in 2018.
- The last three Non-Current Debt figures came in at $13.2 million (Q3 2018), $14.4 million (Q2 2018), and $15.6 million (Q1 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 13.18 Mn |
| Sep 30, 2018 | 13.18 Mn |
| Jun 30, 2018 | 14.42 Mn |
| Jun 30, 2018 | 14.42 Mn |
| Mar 31, 2018 | 15.65 Mn |
| Mar 31, 2018 | 15.65 Mn |
| Dec 31, 2017 | 16.89 Mn |
| Dec 31, 2017 | 16.89 Mn |
| Sep 30, 2017 | 7.40 Mn |
| Sep 30, 2017 | 7.40 Mn |
| Jun 30, 2017 | 8.04 Mn |
| Jun 30, 2017 | 8.04 Mn |
| Mar 31, 2017 | 8.68 Mn |
| Mar 31, 2017 | 8.68 Mn |
| Dec 31, 2016 | 32,000.00 |
| Dec 31, 2016 | 32,000.00 |
| Sep 30, 2016 | 42,000.00 |
| Sep 30, 2016 | 42,000.00 |
| Jun 30, 2016 | 52,000.00 |
| Jun 30, 2016 | 52,000.00 |